Latest posts from Pharma Blogs
WSJ.com: Health Blog » Insurance Ping Pong Can Aggravate TMJ Pain
If you’re clenching and grinding your teeth more as the stock market tumbles, your angst may get worse when you try to file an insurance claim.
iStockphotoDisorders of the TMJ ...
[Link]WSJ.com: Health Blog » Doctors More Likely to Tell Patients About Obvious Errors
Consider two medical scenarios.
In one, a child receives an overdose of insulin and is admitted to the intensive care unit. In the other, a doctor overlooks a lab test, which ...
[Link]Pharmalot » Your Speaker This Evening, Dr. Charles Nemeroff
Ever play ‘Whack-A-Mole?’ You know, you smack the little creature on the head whenever it pops up, although it keeps reappearing elsewhere? Well, Emory University’s Charles Nemeroff, who is the latest ...
[Link]Pharmalot » Your Speaker This Evening, Dr. Charles Nemeroff
Ever play ‘Whack-A-Mole?’ You know, you smack the little creature on the head whenever it pops up, although it keeps reappearing elsewhere? Well, Emory University’s Charles Nemeroff, who is the latest ...
[Link]THE PETER ROST BLOG » The reason the market is crashing.
By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
WSJ.com: Health Blog » Dendreon Shares Climb on Promising Prostate Cancer Data
Dendreon is back. The beleaguered biotech reported that its prostate cancer vaccine Provenge cut the risk of death by 20% compared with a placebo in a clinical test.
As nearly every ...
[Link]Pharma Marketing Blog » As I Predicted, Drug Samples Under Attack!
First it was direct-to-consumer (DTC) advertising, then free gifts to physicians, followed by pharma-funded continuing medical education (CME). Now the distribution of free Rx drug samples to physicians by pharmaceutical ... [Link]
THE PETER ROST BLOG » Why the bailout isn't working and stock markets tumbling.
By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
Pharmalot » Samples Don’t Reach Poor Kids & Have Safety Risks
In an ideal world, free samples would help uninsured patients get a jump on treatment they may not otherwise be able to obtain. But a new study in Pediatrics finds that ...
[Link]WSJ.com: Health Blog » Bristol-Myers Loses ImClone but Gains $1 Billion
Bristol-Myers Squibb lost out on acquiring ImClone today when Eli Lilly swooped in with a higher bid. But Bristol has come out of this thing looking pretty good.
Bristol already owned ...
[Link]Pharmalot » Samples Don’t Reach Poor Kids & Have Safety Risks
In an ideal world, free samples would help uninsured patients get a jump on treatment they may not otherwise be able to obtain. But a new study in Pediatrics finds that ...
[Link]PharmaGossip » Keating - A "must watch" for McCain supporters
This is the story that the media refuses to mention.
With the economic meltdown that we are witnessing, shouldn't the media be reminding the American people that John McCain was ...
[Link]WSJ.com: Health Blog » Study Questions the Value of Free Drug Samples for Kids
In an era when even the drug industry frowns on drug reps giving doctors trinkets and fancy gifts, the drug samples reps give docs to hand out free to patients are ...
[Link]Pharmalot » Dendreon’s Provenge Reduced Prostate Cancer Risk
Amid the stock sell-off, a bright spot appears and, of all things, it turns out to be Dendreon, the controversial and much-maligned little company that continues to press ahead with its ...
[Link]Pharmalot » Dendreon’s Provenge Reduced Prostate Cancer Risk
Amid the stock sell-off, a bright spot appears and, of all things, it turns out to be Dendreon, the controversial and much-maligned little company that continues to press ahead with its ...
[Link]Pharmalot » University of Minnesota May Ban Pharma Gifts
A university medical school task force recommends prohibiting faculty, medical residents and students from receiving gifts from drug and device makers, according to an unreleased report obtained by The Minnesota Daily, ...
[Link]Pharmalot » Alpharma Agrees To Negotiate With King Pharma
Are you surprised? After the usual posturing and harsh language, the two drugmakers have agreed to a confidentiality agreement, according to a filing with the US Securities and Exchange Commission. This, ...
[Link]Pharmalot » University of Minnesota May Ban Pharma Gifts
A university medical school task force recommends prohibiting faculty, medical residents and students from receiving gifts from drug and device makers, according to an unreleased report obtained by The Minnesota Daily, ...
[Link]WSJ.com: Health Blog » Health Care Heats Up in Presidential Campaign
Health wonks who worried that the global financial crisis would eclipse health care talk in the presidential campaign got some good news this weekend.
Barack Obama brought the subject back, attacking ...
[Link]WSJ.com: Health Blog » Nobel Prize Eludes American in Long-Running HIV Dispute
Half of this year’s Nobel Prize in Physiology or Medicine went to Françoise Barré-Sinoussi and Luc Montagnier, two French researchers who discovered ...
[Link]PharmaGossip » Genentech /OSI - Avastin + Tarceva: clinical trials, ain't they a bitch?!
Genentech and OSI Pharmaceuticals have announced top line results from a phase III study evaluating the combination of Avastin and Tarceva as second-line treatment for advanced non-small cell lung cancer. ... [Link]
Pharmalot » Alpharma Agrees To Negotiate With King Pharma
Are you surprised? After the usual posturing and harsh language, the two drugmakers have agreed to a confidentiality agreement, according to a filing with the US Securities and Exchange Commission. This, ...
[Link]In the Pipeline » Imclone Really Does Get Bought
Well, it looks as if I'll finally be able to stop talking about Imclone: the word came out this morning that they've agreed to a $70/share deal with Lilly. Some thoughts ...
[Link]Pharmalot » Roche Cuts Price Of Tarceva Cancer Med In UK
To get convince the UK’s National Institute for Health and Clinical Excellence to pay for its lung cancer treatment, Roche had to cut the price by about $1,000 in order to ...
[Link]Pharmalot » Lilly Agrees To Buy ImClone For $6.5 Billion
After weeks of drama, a deal is finally done. Lilly will pay $70 a share, well above the $62 offered by Bristol-Myers Squibb. In doing so, Lilly gets access to the ...
[Link]Pharmalot » Pharmalot… Pharmalittle… Good Morning
Welcome back. We hope your weekend was enjoyable. We used our to catch up on sundry errands and tidy up around the Pharmalot corporate campus. Now, though, the time has come ...
[Link]WSJ.com: Health Blog » What Financial Crisis? Eli Lilly Buying ImClone for $6.5 Billion
Never mind the credit crunch. Pharma companies are sitting on cash, and they’re desperate to get into the biotech business. Eli Lilly said this morning that it has agreed to buy ...
[Link]Pharmalot » Roche Cuts Price Of Tarceva Cancer Med In UK
To get convince the UK’s National Institute for Health and Clinical Excellence to pay for its lung cancer treatment, Roche had to cut the price by about $1,000 in order to ...
[Link]Pharmalot » Lilly Agrees To Buy ImClone For $6.5 Billion
After weeks of drama, a deal is finally done. Lilly will pay $70 a share, well above the $62 offered by Bristol-Myers Squibb. In doing so, Lilly gets access to the ...
[Link]PharmaGossip » Safety First
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for October 2008 (PDF).
This issue provides a safety update for ergot-derived dopamine agonists and antibiotics ... [Link]
PharmaGossip » Desperate times call for desperate measures
http://www.shatnerhasselhoff.com/ [Link]
Pharmalot » Pharmalot… Pharmalittle… Good Morning
Welcome back. We hope your weekend was enjoyable. We used our to catch up on sundry errands and tidy up around the Pharmalot corporate campus. Now, though, the time has come ...
[Link]Eye on FDA » Targeted Seats in the House of Representatives
On Election Day 2008, all 435 seats in the United States House of Representatives will be up for grabs. attention so far in 2008, but these House races could arguably have the ... [Link]
The IN VIVO Blog » While You Were Advancing
Despite Saturday's game three hiccup the Fightin' Phils advanced to the NLCS this weekend with a 6-2 win over Milwaukee to cap a 3-1 NLDS victory, taking the sting out ... [Link]
PharmaGossip » Health Care Journalists - problem or solution?
Medical research conflicts of interest are in the news lately, thanks to recent congressional hearings by Senator Charles Grassley.
But are journalists part of the problem?
A new study in the Journal of ... [Link]
PharmaGossip » This years Ig Nobel Prize for Medicine
MEDICINE PRIZE. Dan Ariely of Duke University (USA), Rebecca L. Waber of MIT (USA), Baba Shiv of Stanford University (USA), and Ziv Carmon of INSEAD (Singapore) for demonstrating that high-priced ... [Link]
PharmaGossip » Lilly beat BMS to ImClone
ImClone has agreed to be acquired by Eli Lilly for about $6.1 billion, Reuters reports, citing sources familiar with the situation.
More [Link]
PharmaGossip » McCain and Keating
http://www.keatingeconomics.com/
[Link]PharmaGossip » BI / Pfizer - Spiriva: clinical trials, ain't they a bitch!?
Spiriva, marketed by Pfizer and Boehringer Ingelheim, offered no advantage over an inhaled placebo for moderate-to-very-severe chronic obstructive pulmonary disease, or COPD, researchers reported on Sunday.
More
Also, remember this. ... [Link]
Pharmalot » What Rules? Emory Fiddled While Nemeroff Earned
For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the ...
[Link]Pharmalot » What Rules? Emory Fiddled While Nemeroff Earned
For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the ...
[Link]THE PETER ROST BLOG » All these people are allowed to vote!
By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
THE PETER ROST BLOG » Congressional bailout press conference on SNL
By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
THE PETER ROST BLOG » Biden and Palin VP debate on SNL
By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [Link]
Pharm Aid » Free Drugs
This article could be easily be entitled Hijacked Pharmaceuticals. Quietly, there is a growing problem of stolen pharmaceuticals in the United States.
Pharmaceuticals, like 70% of the products in the U.S., ... [Link]
PharmaGossip » Forest Laboratories - values and transfer pricing
— Howard Solomon , Chairman and Chief Executive Officer
Forest Laboratories, a US pharmaceutical firm, has channelled more than $2 billion in revenues through its Irish ... [Link]
PharmaGossip » Charles "King of Bling" Nemeroff - leader of the Pharma Psych Crew
Back stories here and here.
But now - meet the new "King of Bling"! Emory's very own Chuck Nemeroff.
David Armstrong of the Wall Street Journal and Gardiner Harris of the New York ... [Link]
PharmaGossip » Well - it is Sunday!
Religion - LOL.
Bill on The View:
http://uk.youtube.com/watch?v=dkfPZnyMaEY
http://uk.youtube.com/watch?v=nCrPWWqNl1I
[Link]PharmaGossip » Let the subshine in
PharmaGossip » Late Nite Jokers
[Link]
